載入...
Phase I study of single-dose BMY-28100, a new oral cephalosporin.
The objective of this Phase I study was to evaluate the safety, tolerance, and pharmacokinetics of BMY-28100 in 36 male subjects after the administration of single oral doses of 250, 500, and 1,000 mg. The subjects were divided into groups of 12 per dose group. All subjects completed the study, and...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
1990
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC171556/ https://ncbi.nlm.nih.gov/pubmed/2327766 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|